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Gilles de la Tourette Sydrome (TS) is a childhood onset neurodevelopmental disorder,
characterized phenotypically by the presence of multiple motor and vocal tics. It is often
accompanied by multiple psychiatric comorbidities, with Attention Deficit/Hyperactivity
Disorder (ADHD) among the most common. The extensive co-occurrence of the two
disorders suggests a shared genetic background. A major step toward the elucidation of
the genetic architecture of TS was undertaken by the first TS Genome-wide Association
Study (GWAS) reporting 552 SNPs that were moderately associated with TS (p < 1E-3).
Similarly, initial ADHD GWAS attempts and meta-analysis were not able to produce
genome-wide significant findings, but have provided insight to the genetic basis of the
disorder. Here, we examine the common genetic background of the two neuropsychiatric
phenotypes, by meta-analyzing the 552 top hits in the TS GWASwith the results of ADHD
first GWASs. We identify 19 significant SNPs, with the top four implicated genes being
TBC1D7, GUCY1A3, RAP1GDS1, and CHST11. TBCD17 harbors the top scoring SNP,
rs1866863 (p:3.23E-07), located in a regulatory region downstream of the gene, and the
third best-scoring SNP, rs2458304 (p:2.54E-06), located within an intron of the gene.
Both variants were in linkage disequilibrium with eQTL rs499818, indicating a role in the
expression levels of the gene. TBC1D7 is the third subunit of the TSC1/TSC2 complex, an
inhibitor of the mTOR signaling pathway, with a central role in cell growth and autophagy.
The top genes implicated by our study indicate a complex and intricate interplay between
them, warranting further investigation into a possibly shared etiological mechanism for
TS and ADHD.
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1. INTRODUCTION
Gilles de la Tourette Syndrome (TS) is a childhood onset neuropsychiatric disorder characterized by
amultitude of motor and vocal tics that last longer than a year. Its international prevalence has been
estimated to be approximately 1% (Robertson et al., 2009). A recent systematic review and meta-
analysis on the population prevalence of TS, refined its prevalence estimate in children to 0.3–1%
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(Scharf et al., 2015). It presents a significant gender bias, with
73% of its patients being male, and the male patients being more
likely to develop comorbid disorders (Robertson et al., 2015).
TS is often associated with other neuropsychiatric disorders,
including Attention Deficit/Hyperactivity Disorder (ADHD),
Obsessive Compulsive Disorder (OCD), depression and anxiety
(Robertson, 2006).
The first genome-wide association study (GWAS) on TS was
undertaken by the Tourette Syndrome Association International
Consortium for Genetics (TSAICG) (Scharf et al., 2013). In their
primary analysis, no SNPs achieved an association p-value of
genome-wide significance, however this study provided the basis
for subsequent studies, as the top signals that attained a p < 10−3
were found to be significantly enriched for functional variants.
The Gilles de la Tourette Syndrome GWAS Replication Initiative
(GGRI) undertook a replication (Paschou et al., 2014) of the
first GWAS study, by selecting the top LD-independent SNPs
and additional SNPs singificantly enriched in eQTL or mQTLs
for genotyping in 609 European TS patients and 610 ancestry-
matched controls, recruited from different European countries
and Canada. This replication study enriched the significance of
the selected SNPs and providedmore evidence toward the genetic
aetiology of TS.
On the other hand, initial GWAS attempts on ADHD also did
not yield genome-wide significant results (Neale et al., 2008;Mick
et al., 2010; Neale et al., 2010a; Lesch et al., 2008). To that end, a
meta-analysis was conducted by Neale et al. (2010b), aggregating
the results of the previous GWAS projects and meta-analyzing
them. This meta-analysis could not produce any significant
results either, but, similar to the TS GWAS, it set the groundwork
for the elucidation of the genetic background of ADHD.
The relationship of TS with ADHD is well established
(Karagiannidis et al., 2016). Individuals with ADHD commonly
present tics, and in individuals with TS and tics, ADHD is
a significant commorbidity. ADHD occurs in a significant
proportion of TS patients, ranging from 21 to 90% in studied
cohorts (Robertson, 2006). This phenotypic association is a major
indication of a common genetic background between the two
disorders. Furthermore, a recent study investigating the genetic
correlation among neuropsychiatric and neurological disease
based onGWAS results for each disorder, also recovered a genetic
correlation between TS and ADHD (Anttila et al., 2016).
This is the first study to attempt to identify a shared genetic
component between TS and ADHD. We used summary statistics
from the latest large-scale genomic efforts to unravel the genetic
background of TS and ADHD and derived the combined effects
of shared polymorphisms between the two datasets, highlighting
genes and pathways that may play a role in the shared etiology
between the two disorders.
2. MATERIALS AND METHODS
2.1. Data Sources
For our study we focused on the combination of the known
effects of SNPs on the phenotypes of TS and ADHD.
Scharf et al in their study (Scharf et al., 2013) performed
a GWAS and meta-analysis on a total of 1285 cases and 4964
ancestry-matched controls of European ancestry, genotyped on
484,295 SNPs. The dataset was analyzed in three split cohorts and
was subsequently meta-analyzed. The study reported 552 SNPs
associated with TS that acquired a p < 10−3.
We acquired the ADHD meta-GWAS whole-genome
summary statistics from the study conducted by the ADHD
subgroup of the Psychiatric GWAS consortium (Neale et al.,
2010b; Cross-Disorder Group of the Psychiatric Genomics
Consortium, 2013). The total sample size consisted of 896 cases,
2455 controls and 2064 trios genotyped and then imputed to
1,230,536 SNPs.
We used the publically available top SNPs with a p < 10−3
associated with TS (Scharf et al., 2013) and meta-analyzed them
with the results of the ADHD meta-analysis (Neale et al., 2010b;
Cross-Disorder Group of the Psychiatric Genomics Consortium,
2013). We identified 489 SNPs that were overlapping between the
two sources to proceed with the meta-analysis.
2.2. Meta-Analytical Procedure
We combined the effects of the SNPs in each phenotype,
following a meta-analytic approach, assuming a fixed-effects
model, using the Z-Scores as the effect and the number of cases
in each study as the weight. The heterogeneity of each analyzed
SNP was assessed using Cochran’s Q-test and I2 statistic. The
analysis was performed using the METAL (Willer et al., 2010)
software. The significance threshold was set using the Bonferroni
correction for multiple testing.
2.3. Annotation and Functional Significance
We proceeded to analyze the significant SNPs using the
ENSEMBL Variant Effect Predictor (McLaren et al., 2010) to
annotate and explore the possible functional characteristics
of the associated variants. The genomic positions of the
variants were converted to the GRCh38 assembly coordinates.
For the investigation of the allelic frequencies, and the
linkage disequilibrium (LD) patterns we used data from the
1000Genomes project (1000 Genomes Project Consortium et al.,
2015) and the LDlink software (Machiela and Chanock, 2014).
To investigate the association of the variants and their respective
genes with tissue expression levels we used the GTEx portal
(The GTEx Consortium, 2013) and the Expression Atlas database
(Petryszak et al., 2014). The annotation and exploration of the
genomic structure of the identified loci was further assisted by the
use of LdOOKUP, developed by Shaun Purcell (https://purces04.
u.hpc.mssm.edu/ldookup/ldookup.cgi).
We have uploaded all codes necessary to confirm our
conclusions and they can be found at https://github.com/ftsetsos/
tsadhdmeta2016.
3. RESULTS
The meta-analysis produced 19 significant SNPs, out of the
total 489 tested. The significance threshold was set using
the Bonferroni correction for multiple testing, setting the
significance level at a p-value of 0.0001022.
Of these 19 SNPs, five attained the lowest p-values, coupled
with no evidence of confounding heterogeneity (I2 = 0). The
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tested SNPs that present the most significant heterogeneity (Het
p < 0.05) were the ones that had achieved a p < 0.05 in the
original ADHD meta-analysis. The annotation showed that the
majority of the significant variants are located in introns, two are
in regulatory regions, while three are intergenic.
The first and third top hits (rs1866863, p:3.23E-07 and
rs2458304, p:2.54E-06) reside on a LD-block of 54.19 kb on
the 6p24.1 region. They show significant linkage disequilibrium
between them (D′: 0.909, R2: 0.725). The former is a variant
located in the regulatory region downstream of the TBC1D7
gene, and the latter is an intron variant in the same gene. Both are
in LD with the rs499818 eQTL (R2: 0.59 and 0.48 respectively),
suggesting an interplay with the expression levels of the
gene.
Chromosome 4 hosts the second (rs2705462, p:1.44E-06),
the fourth (rs17561798, p:9.89E-06), and two lower-ranked
variants(rs477897, p:8.65E-05 and rs2285084, p:1.00E-04), each
residing in four distinct, LD-independent loci. The most
significant variant, rs2705462, is located in the intergenic region
upstream of the GUCY1A3 gene in the 4q32.1 region on a LD-
block of 46.63 kb. The next variant, rs17561798, resides in the
4q23 region and is an intron variant inside the RAP1GDS1 gene.
The variant rs477897 is located within an intron of ADD1 in the
region 4p16.3 captures an area of 125.59 kb, implicating the genes
H3BP2, ADD1, MFSD10, NOP14. The intron variant rs2285084
is located in the gene ANXA10. The gene is included in the locus
4q32.3 in a high LD region of 330.00 kb that contains also the
genes ANXA10, DDX60, DDX60L.
The fifth most significant SNP, rs1650137 (p:1.76E-05), is
located on 12q23.3 in an intron of the gene CHST11. This region
is inside a LD-block that extends for 39.68 kb. The variant
rs2246417 came up as the sixth most significant (p:1.95E-05),
residing in the locus 21q22.3 in a LD-block of 16.29 kb, within
an intron of the LINC00316 gene.
The variant rs11716445 (p: 8.01E-05) resides in the 3p21.31
region. This region is characterized by a very large area with an
extended high-LD block of 1941.64 kb and it contains 70 genes,
with the first genes being PLXNB1, CCDC51, TMA7, ATRIP,
TREX1, and ending with HYAL2, TUSC2, RASSF1, ZMYND10,
NPRL2. The variant itself is located in the intron of the RHOA
gene. It is one of the lower-ranked variants that achievedminimal
confounding by heterogeneity.
The locus 7p21.3 hosts the intergenic variants rs13244651
(p:4.11E-05) and rs17531553 (p:7.08E-05) that are part of a LD-
block sized at 103.93 kb, albeit with no known genes close to
them, and no strong suggestive results for any direct functional
implication.
Two genomic regions on chromosome 9 are implicated by our
results. A region of 58.16 kb in the 9p24.2 locus contains the
variants rs1007021 (p: 4.38E-05) and rs1007022 (p:7.68E-05) in
the introns of KCNV2, showing strong LD between them (D′:
1.000R2:0.803). The region 9q31.1 contains the intergenic variant
rs7858600 (p:5.30E-05) inside a region of 27.35 kb.
In the locus 10q21.1, the intergenic variant rs1896373
(p:7.46E-05) captures a region of 47.58 kb, in strong LD with the
rs1919459 eQTL (R2: 0.97) that is associated with the regulation
of DKK1. The variant rs4789936 (p:8.92E-05) is located in the
17q25.3 locsus, in a LD-region 34.19 kb, and is an intron variant
of the gene TIMP2 while on it is non-coding exon variant in
the gene CEP295NL. In the locus 16q12.1, the variant rs7203818
(p:1.01E-04) resides in a LD-block of 21.12 kb within an intron of
ZNF423.
On chromosome 13, the LD-associated variants rs7336083
and rs9319159 (D′: 0.974 R2: 0.897) represent an LD-block of
292.34 kb and reside in the introns of the LINC00351 gene. The
result is mostly driven by the p-value attained in the TS meta-
analysis and there is evidence of significant confounding caused
by heterogeneity.
We summarize the results of the meta-analysis on Table 1.
In Table 2, we provide the annotation we generated for each
significant variant, and in Table 3 we provide the LD regions
associated with the variants. The full results of the meta-analysis
on the 489 tested SNPs are described in more detail in the
Supplementary Material.
4. DISCUSSION
This is the first study to identify shared genetic factors underlying
TS and ADHD, two closely related and often co-occurring
neuropsychiatric disorders (Karagiannidis et al., 2016). Wemeta-
analyzed 489 of the top hit SNPs in the first TS GWAS, that
had also been tested in ADHD published GWASs and meta-
analysis. Our own meta-analysis highlights genes that may
play a role in the shared etiology between TS and ADHD. 19
SNPs attained in the meta-analysis a p-value lower than the
significance threshold, as denoted by the Bonferroni correction
approach for multiple testing. All significant SNPs had the same
direction of effect, which is indicative of a shared mechanism
of disease development. A minority of those had not presented
any association with ADHD in the original ADHDmeta-analysis,
with the resulting combined p-value being driven mostly by the
p-value acquired from the TS study.
The five most significant SNPs had achieved moderate
association p-values in the original ADHD study, and thus
attained high p-values with no heterogeneity-based confounding
in our meta-analysis, becoming strong candidates for the shared
genomic background of the disorders.
TBC1D7 (TBC1 Domain Family, Member 7) is a prominent
gene in our results, with two variants achieving the top and
the third best p-values in our study. The top scoring SNP is
located in a regulatory region downstream of the gene, while the
third top is located within an intron of the gene. The associated
variants have demonstrated linkage disequilibrium with a known
eQTL for the expression of the gene, further substantiating
their implication into the regulation of the expression profile
of the gene. Expression profiling in Expression Atlas and GTEx
show significant overexpression in the brain, the heart, the
testis and in blood cells. The product of the gene is the
third subunit of the TSC1-TSC2 complex with a Rheb-GAP
activity, and is ubiquitously present in the complex (Dibble
et al., 2012). An eQTL for TBC1D7 has been significantly
associated with migraine and migraine without aura in a study of
23,285 individuals withmigraine and 95,425 population-matched
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TABLE 1 | Significant results of the meta-analysis.
SNP Chromosome Position Allele TS ADHD Meta Direction I2 Het P-value
rs1866863 6 13336583 A 6.09E-04 1.51E-04 3.23E-07 – 0 0.9916
rs2705462 4 155648650 T 8.30E-04 5.09E-04 1.44E-06 – 0 0.875
rs2458304 6 13323663 A 3.74E-04 1.77E-03 2.54E-06 – 0 0.5818
rs17561798 4 98314790 A 3.80E-04 6.01E-03 9.89E-06 – 0 0.4226
rs1650137 12 104586532 A 4.01E-04 9.58E-03 1.76E-05 ++ 0 0.3702
rs2246417 21 45339588 T 2.54E-04 1.42E-02 1.95E-05 ++ 13.7 0.2816
rs9319159 13 85445305 T 1.15E-05 1.11E-01 3.77E-05 – 79.2 0.02837
rs13244651 7 10308596 T 5.03E-05 6.18E-02 4.11E-05 ++ 67.8 0.07797
rs1007021 9 2723657 A 5.36E-05 6.26E-02 4.38E-05 ++ 67.5 0.07919
rs7858600 9 102764080 A 2.26E-04 3.42E-02 5.30E-05 ++ 42.8 0.1859
rs7336083 13 85429252 A 9.49E-06 1.71E-01 6.88E-05 – 82.3 0.01756
rs17531553 7 10311703 A 9.40E-05 6.73E-02 7.08E-05 ++ 64.5 0.09348
rs1896373 10 52334599 T 3.46E-04 3.50E-02 7.46E-05 ++ 35.8 0.2121
rs1007022 9 2723761 A 8.85E-05 7.33E-02 7.68E-05 ++ 66 0.08647
rs11716445 3 49368662 A 7.95E-04 2.22E-02 8.01E-05 ++ 0 0.336
rs477897 4 168177763 A 3.10E-04 4.19E-02 8.65E-05 ++ 42.5 0.1874
rs4789936 17 78901892 T 7.12E-04 2.61E-02 8.92E-05 – 5.1 0.3047
rs2285084 4 2904558 A 8.07E-04 2.66E-02 1.00E-04 – 1 0.3149
rs7203818 16 49610387 A 4.03E-04 4.09E-02 1.01E-04 ++ 37.1 0.2075
Here we report the p-values attained in each study, the combined p-value after the meta-analysis and the direction of the effect. Alongside these statistics, we also present Cochran’s
I2 value and the heterogeneity p-value for each SNP.
TABLE 2 | Functional annotation of the significant SNPs of the meta-analysis.
SNP Chromosome Position P-value Gene Impact Global Freq EUR Freq
rs1866863 6 13336583 3.23E-07 TBC1D7 Regulatory region A:0.4583 G:0.3907
rs2705462 4 155648650 1.44E-06 GUCY1A3 Intergenic T:0.2041 T:0.2893
rs2458304 6 13323663 2.54E-06 TBC1D7 Intron A:0.4287 G:0.3598
rs17561798 4 98314790 9.89E-06 RAP1GDS1 Intron G:0.0110 G:0.0398
rs1650137 12 104586532 1.76E-05 CHST11 Intron A:0.2911 A:0.2038
rs2246417 21 45339588 1.95E-05 LINC00316 Intron C:0.2428 C:0.1461
rs9319159 13 85445305 3.77E-05 LINC00351 Intron T:0.3259 T:0.3797
rs13244651 7 10308596 4.11E-05 Intergenic Intergenic G:0.3724 G:0.4066
rs1007021 9 2723657 4.38E-05 KCNV2 Intron A:0.1388 A:0.0696
rs7858600 9 102764080 5.30E-05 Intergenic Intergenic G:0.3694 A:0.4861
rs7336083 13 85429252 6.88E-05 LINC00351 Intron A:0.3311 A:0.3668
rs17531553 7 10311703 7.08E-05 Intergenic Intergenic G:0.3746 G:0.4066
rs1896373 10 52334599 7.46E-05 Intergenic Regulatory region T:0.4994 T:0.4513
rs1007022 9 2723761 7.68E-05 KCNV2 Intron A:0.0649 A:0.0567
rs11716445 3 49368662 8.01E-05 RHOA Intron A:0.03115 A:0.1024
rs477897 4 168177763 8.65E-05 ANXA10 Intron G:0.1148 G:0.2256
rs4789936 17 78901892 8.92E-05 CEP295NL Intron T:0.4407 T:0.5219
rs2285084 4 2904558 1.00E-04 ADD1 Intron G:0.2414 G:0.2087
rs7203818 16 49610387 1.01E-04 ZNF423 Intron A:0.2169 A:0.1581
Here we present the genes in which the SNPs are located, along with the frequency of the alleles in global and european populations, according to 1000 Genomes.
controls (Anttila et al., 2013). Interestingly, Anttila et al (Anttila
et al., 2016) also picked up a genetic correlation between TS and
migraine.
The presence of TBC1D7 in the TSC1/2 complex creates
a suggestive functional link between the proteins. The role
of the TSC1/2 complex is indicative of TBC1D7’s role in the
brain and neuropsychiatric disease, as an important component
of the active complex. The TSC1 (Tuberous Sclerosis 1)
and TSC2 (Tuberous Sclerosis 2) genes have an important
role in the aetiology of Tuberous Sclerosis Complex (TSC).
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TABLE 3 | LD-regions that are captured by the top SNPs in our study.
SNP Chromosome Region Length (kb) Gene(s) eQTL
rs11716445 3 48446237..50387873 1941.64 PLXNB1;...NPRL2 –
rs2705462 4 156557255..156603882 46.63 GUCY1A3 –
rs477897 4 168980017..169310018 330.00 ANXA10; DDX60; DDX60L –
rs2285084 4 2836195..2961783 125.59 SH3BP2; ADD1; MFSD10; NOP14 –
rs1866863 6 13298395..13352581 54.19 TBC1D7 1.7e-10 (rs499818)
rs17531553 7 10255806..10359733 103.93 – –
rs7858600 9 105517266..105544614 27.35 – –
rs1007021 9 2699874..2758034 58.16 KCNV2 –
rs1896373 10 54068904..54116478 47.58 DKK1 2.18e-05 (rs1919459)
rs1650137 12 104977289..105016971 39.68 CHST11 –
rs7336083 13 85893863..86186202 292.34 – –
rs7203818 16 49637407..49658524 21.12 ZNF423 –
rs4789936 17 76894415..76928600 34.19 TIMP2; LOC100653515 –
rs2246417 21 46744358..46760648 16.29 – –
Regions that are in linkage disequilibrium with the top SNPs, along with the range of genes residing in those regions and any linked known eQTLs. Genomic coordinates are in reference
to the GRCh37 assembly.
TSC is a neurodevelopmental disorder that typically presents
with tumours of the brain, skin, heart, lungs, and kidneys,
but also neurological disorders such as epilepsy, cognitive
disability and autism. The TSC1/2 complex acts as an inhibitor
of the mechanistic target of rapamycin (mTOR) signaling
pathway which plays a central role in cell growth, proliferation,
autophagy and thus also neurodevelopment (Henske et al., 2016).
The TSC pathway regulates neuronal structure and function,
and is sensitive to gene-dosage effects, showing degrees of
haploinsufficiency (Tavazoie et al., 2005). TSC1 has also been
implicated in bipolar disorder, without attaining genome-wide
significance (Scott et al., 2009). Furthermore, TSC1 has been
shown to have a neuroprotective role in hippocampal regions of
the brain, protecting against ischemic events (Papadakis et al.,
2013).
RAP1GDS1 (RAP1, GTP-GDP dissociation stimulator 1)
is a GDP/GTP exchange protein with GTPase activity (Riess
et al., 1993). It is located on chromosome 4 and is the third
top locus to be implicated in the shared genetic background,
with the associated variant residing in the intron of the
gene. It is significantly overexpressed in brain and nervous
tissues. RAP1GDS1 has been shown to interact with RHO
(Ras homolog gene family, member A), that has also been
implicated in this study, in a cascade involving interactions
with multiple signaling proteins (Vikis et al., 2002; Berg
et al., 2010; Hamel et al., 2011). CHST11 (carbohydrate
chondroitin 4 sulfotransferase 11) is involved in the sulfation
of chondroitin (Klppel, 2010), which is a key element of the
brain matrix (Kwok et al., 2012). It is expressed in areas
of the brain, including the hippocampus and the caudate
nucleus. GUCY1A3 (Guanylate cyclase soluble subunit alpha-
3) functions as the main receptor for nitric oxide, and
has been implicated in Moyamoya disease, a disease causing
constriction in arteries and brain ischemic events (Wallace et al.,
2016).
5. CONCLUSION
We investigate, for the first time, the common genetic
background between TS and ADHD on a genomewide scale
and provide evidence that specific genes may underlie both
disorders. The implicated variants lie on genes that appear to
have a complex interplay between them. The main theme of the
results is the Ras signaling cascade in the brain, with TBC1D7 and
RAP1GDS1 being key elements of the brain signaling pathways.
Interestingly, an additional theme emerging from the data, is
related to brain ischemic response, with GUCY1A3 and the
TSC1/2 complex (which includes TBC1D7) as implicated as
factors. Intriguingly, one of our top hits, TBC1D7, implicates
the mTOR signaling pathway and autophagy processes (Dibble
et al., 2012). Furthermore, our analysis also points to CHST11,
which has been shown to regulate the brain extracellular matrix,
by affecting the chondroitin sulfation levels. Therefore, further
investigation in the role of the respective genes in the shared
genetic aetiology of TS and ADHD is warranted. Our results
provide an intriguing insight into the shared mechanism of
common neuropsychiatric disorders.
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